Groupe Bruxelles Lambert SA (FRA:EAI)

Blueprint Medicines Statistics

Total Valuation

FRA:EAI has a market cap or net worth of EUR 8.85 billion. The enterprise value is 15.06 billion.

Market Cap	8.85B
Enterprise Value	15.06B

Important Dates

The last earnings date was Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	May 9, 2025

Share Statistics

Current Share Class	122.77M
Shares Outstanding	n/a
Shares Change (YoY)	-6.70%
Shares Change (QoQ)	-1.71%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	68.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	25.57
PS Ratio	1.37
PB Ratio	0.62
P/TBV Ratio	1.68
P/FCF Ratio	12.94
P/OCF Ratio	7.34
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.67, with an EV/FCF ratio of 22.04.

EV / Earnings	-146.68
EV / Sales	2.33
EV / EBITDA	12.67
EV / EBIT	24.01
EV / FCF	22.04

Financial Position

The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.53.

Current Ratio	1.91
Quick Ratio	1.38
Debt / Equity	0.53
Debt / EBITDA	7.09
Debt / FCF	11.19
Interest Coverage	1.42

Financial Efficiency

Return on equity (ROE) is -1.41% and return on invested capital (ROIC) is 1.39%.

Return on Equity (ROE)	-1.41%
Return on Assets (ROA)	1.21%
Return on Invested Capital (ROIC)	1.39%
Return on Capital Employed (ROCE)	2.29%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	69
Asset Turnover	0.24
Inventory Turnover	1.83

Taxes

In the past 12 months, FRA:EAI has paid 88.00 million in taxes.

Income Tax	88.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.42% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+7.42%
50-Day Moving Average	72.96
200-Day Moving Average	68.98
Relative Strength Index (RSI)	44.76
Average Volume (20 Days)	262

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:EAI had revenue of EUR 6.45 billion and -102.70 million in losses. Loss per share was -0.79.

Revenue	6.45B
Gross Profit	4.46B
Operating Income	516.70M
Pretax Income	-127.40M
Net Income	-102.70M
EBITDA	946.70M
EBIT	516.70M
Loss Per Share	-0.79

Balance Sheet

The company has 3.37 billion in cash and 7.65 billion in debt, giving a net cash position of -4.27 billion.

Cash & Cash Equivalents	3.37B
Total Debt	7.65B
Net Cash	-4.27B
Net Cash Per Share	n/a
Equity (Book Value)	14.30B
Book Value Per Share	97.43
Working Capital	2.74B

Cash Flow

In the last 12 months, operating cash flow was 1.21 billion and capital expenditures -521.60 million, giving a free cash flow of 683.40 million.

Operating Cash Flow	1.21B
Capital Expenditures	-521.60M
Free Cash Flow	683.40M
FCF Per Share	n/a

Margins

Gross margin is 69.10%, with operating and profit margins of 8.01% and -1.59%.

Gross Margin	69.10%
Operating Margin	8.01%
Pretax Margin	-1.97%
Profit Margin	-1.59%
EBITDA Margin	14.67%
EBIT Margin	8.01%
FCF Margin	10.59%

Dividends & Yields

This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 4.57%.

Dividend Per Share	3.50
Dividend Yield	4.57%
Dividend Growth (YoY)	81.82%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	6.70%
Shareholder Yield	11.27%
Earnings Yield	-1.16%
FCF Yield	7.73%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6